Brainstorm Cell Therapeutics, Inc. (BCLI)

1.07 -0.18 (-14.40%) USD  |  OTCM  |  Sep 03, 16:00
More

Brainstorm Cell Therapeutics Cash and Short Term Investments (Annual) : 0.029M for Dec. 31, 2025

Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for BCLI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 2001. Start Trial.
Date Value
December 31, 2025 0.029M
December 31, 2024 0.187M
December 31, 2023 1.30M
December 31, 2022 2.983M
December 31, 2021 22.09M
December 31, 2020 41.94M
December 31, 2019 0.569M
December 31, 2018 7.064M
December 31, 2017 7.756M
December 31, 2016 9.99M
December 31, 2015 15.96M
December 31, 2014 8.541M
December 31, 2013 3.503M
Date Value
December 31, 2012 4.086M
December 31, 2011 1.923M
December 31, 2010 0.093M
December 31, 2009 0.001M
December 31, 2008 0.038M
December 31, 2007 0.121M
December 31, 2006 0.0924M
March 31, 2006
March 31, 2005 0.5577M
March 31, 2004 0.0046M
March 31, 2003 0.01M
March 31, 2002 0.0361M
March 31, 2001 0.0535M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
NovelStem International Corp. 0.0003M
Summit Therapeutics, Inc. 713.76M
Kezar Life Sciences, Inc. 71.88M
Protara Therapeutics, Inc. 155.55M
Clene, Inc. 5.189M